Abstract 419P
Background
Mammogram is a mandatory screening test for women from 40 years of age in the most parts of the world. While the structural screening for Coronary artery disease doesn’t exist but Women with breast cancer share common risk factors for coronary artery disease (CAD) as well. By using mammogram we can detect the potentially high risk patients, common for both the diseases and this is going to help in long way. Literature suggests that breast arterial classification exist in up to 8- 26% in women undergoing mammogram. In this study we have explored incidence of the total calcifications on mammogram and the percentage of people having Coronary artery diseases in a retrospective to manner.
Methods
It’s a retrospective observation of all mammograms done in past one year for routine screening from three institutes during the study period 2020-2021. Those with calcifications were interviewed and for the willing population we evaluated the coronary artery disease status clinically and radiologically. The mammogram calcifications were classified into mild, moderate, and severe as per the existing literature, so as the findings of the coronary angiogram. The incidence of the calcifications and the presence of CAD in the population were represented as percentages. Medcalc software version 10.1 was used for the analysis.
Results
There are 400 subjects whose complete case records besides the mammograms were available during the study period. Out of these patients 45 had some form of calcifications on mammograms with varying severity. Out of the 45 subjects 38 patients had coronary angiogram testing (either conventional or CT). We could observe 30 of them harboring moderate to severe atherosclerotic changes and varying degree of coronary artery stenosis.
Conclusions
Conclusion The results here hence strongly advocate the radiologists to report the same findings and should prompt the screening physician to encourage the patients for their cardiac risk assessment. In these multi-centre study patients with suspected coronary artery disease, our timely intervention changed the diagnosis and management of patients, who underwent mammogram for screening, but were unaware of the coronary disease, which led to improved outcomes on cardiac aspects.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
YO11 - Satisfactory response after Rituximab-Bendamustin in Poor Performance Status Geriatric with Relapsed DLBCL
Presenter: Yasjudan Putra
Session: Poster viewing 06
YO12 - Allogeneic hematopoietic stem cell transplant in a case of acute myeloid leukaemia with end stage renal disease
Presenter: DEVYANI SURANGE
Session: Poster viewing 06
YO13 - Rosai-Dorfman Disease Presenting with Multiple Contiguous Lymphadenopathy: A Case Report
Presenter: Lean Marx Maaño
Session: Poster viewing 06
YO15 - Nasopharyngeal carcinoma in pregnancy: A Case Report
Presenter: Mary Antonette Ong
Session: Poster viewing 06
YO16 - New onset SIADH masquerading progression in esthesioneuroblastoma
Presenter: Muthu Manikandan
Session: Poster viewing 06
YO17 - Olfactory Neuroblastoma with Cervical Lymph Node Metastases in a 21- Year old Filipino Woman: A Case Report
Presenter: Mary Antonette Ong
Session: Poster viewing 06
YO18 - Challenges in Provision of Patient centered care with a Practical approach in a Resource-limited setting - Steven Johnson Syndrome – Toxic Epidermal Necrolysis (SJS-TEN) overlap related to Phenytoin use and review of logistical challenges related to care provision - a Case Report.
Presenter: Rahul D. Arora
Session: Poster viewing 06
YO19 - Posterior Reversible Encephalopathy Syndrome associated with Pharmacological management of Bowel obstruction at the end of life – a review of two cases separated by 5 years
Presenter: Rahul D. Arora
Session: Poster viewing 06
YO20 - A case of drug-induced large vessel vasculitis with hoarseness as the chief complaint caused by pegfilgrastim during chemotherapy
Presenter: Takuya Sato
Session: Poster viewing 06
YO23 - Neo-adjuvant immunotherapy in operable non-small cell lung carcinoma
Presenter: Padmini S N
Session: Poster viewing 06